Steven Cohen’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-192,594
Closed -$15.8M – 4553
2026
Q2
$12.8M Buy
+192,594
New +$16.3M 0.01% 1132
2023
Q3
– Sell
-834
Closed -$70.1K – 2873
2023
Q2
$70.1K Sell
834
-266
-24% -$20.4K ﹤0.01% 1574
2023
Q1
$83.3K Buy
+1,100
New +$76.1K ﹤0.01% 1671
2022
Q3
– Sell
-11,100
Closed -$349K – 1736
2022
Q2
$349K Buy
+11,100
New +$296K ﹤0.01% 1230
2021
Q3
– Sell
-322,000
Closed -$10.7M – 1246
2021
Q2
$10.7M Buy
+322,000
New +$8.92M 0.05% 439
2021
Q1
– Sell
-89,800
Closed -$1.79M – 1180
2020
Q4
$1.79M Sell
89,800
-209
-0.2% -$3.09K 0.01% 745
2020
Q3
$1.24M Buy
90,009
+58,735
+188% +$1.01M 0.01% 756
2020
Q2
$560K Buy
+31,274
New +$489K ﹤0.01% 706

Other funds holding TMDX

Steven Cohen's TMDX Position: Q3 2026 in Review

Steven Cohen sold out of Transmedics (TMDX) in Q3 2026, closing a stake of 192,594 shares — an estimated $15.8M sold.

Steven Cohen first reported a position in TMDX in Q2 2020 and held it in 8 quarters. The position peaked at $12.8M in Q2 2026. 386 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Steven Cohen reported no remaining Transmedics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 192,594 Transmedics shares in Q3 2026, an estimated $15.8M.
  • Steven Cohen first reported a position in Transmedics in Q2 2020 and held it in 8 quarters.
  • Steven Cohen's Transmedics position peaked at $12.8M in Q2 2026.
  • 386 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.